Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects
- Conditions
- Interventions
- First Posted Date
- 2023-09-26
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06054698
Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects
- Conditions
- Interventions
- First Posted Date
- 2023-07-28
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 199
- Registration Number
- NCT05966272
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
A Relative Bioavailability Study of HRS9531 in Healthy Subjects
- First Posted Date
- 2023-06-08
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT05893576
- Locations
- 🇨🇳
Central hospital affiliated to Shandong first mecical university, Jinan, Shandong, China
Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes
- Conditions
- Interventions
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 249
- Registration Number
- NCT05881837
- Locations
- 🇨🇳
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
🇨🇳The people's hospital of Longhua.Shenzhen, Shenzhen, Guangdong, China
🇨🇳The First People's Hospital Of Lianyungang, Lianyungang, Jiangsu, China
Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 85
- Registration Number
- NCT05808374
- Locations
- 🇨🇳
The First Affiliated Hospital of China University of Science and Technology, Hefei, Anhui, China
A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral Nutrition
- Conditions
- Interventions
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT05788588
- Locations
- 🇨🇳
Hefei First People's Hospital, Hefei, Anhui, China
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS3797 in Healthy Subjects
- First Posted Date
- 2023-01-27
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 35
- Registration Number
- NCT05701826
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT05516966
- Locations
- 🇨🇳
Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China
Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 754
- Registration Number
- NCT05509634
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center Yuexiu Campus, Guangzhou, Guangdong, China
Study of HR20013 for Injection in Patients With Malignant Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT05465681
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China